Literature DB >> 7876511

Cytomegalovirus as an exacerbating factor in ulcerative colitis.

E V Loftus1, G L Alexander, H A Carpenter.   

Abstract

Cytomegalovirus (CMV) colitis has been reported infrequently in patients with underlying inflammatory bowel disease, and usually in those who are taking long-term corticosteroid drugs and who are potentially immunosuppressed. We report a 39-year-old man with long-standing ulcerative colitis, taking only sulfasalazine, who developed a viral prodrome followed by bloody diarrhea. Severe colitis was noted on endoscopy. He worsened with intravenous steroid and antibiotic drugs. Flexible sigmoidoscopy with biopsy before a contemplated colectomy revealed a moderately active colitis with large cells containing intranuclear inclusions scattered throughout the biopsies, characteristic of CMV colitis. Serologic and immunologic studies suggested recent CMV infection. The patient improved with intravenous ganciclovir and a steroid taper, and colectomy was avoided. CMV colitis is a potentially treatable cause of fulminant colitis.

Entities:  

Mesh:

Year:  1994        PMID: 7876511     DOI: 10.1097/00004836-199412000-00010

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  15 in total

1.  Fulminant Ulcerative Colitis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-06

Review 2.  Cytomegalovirus and inflammatory bowel disease: is there a link?

Authors:  Valeria Criscuoli; Maria-Rosa Rizzuto; Mario Cottone
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

3.  Possible role of human cytomegalovirus in pouchitis after proctocolectomy with ileal pouch-anal anastomosis in patients with ulcerative colitis.

Authors:  Damian Casadesus; Tatsuo Tani; Toshifumi Wakai; Satoshi Maruyama; Tsuneo Iiai; Haruhiko Okamoto; Katsuyoshi Hatakeyama
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

4.  Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis.

Authors:  Valeria Criscuoli; Maria Rosa Rizzuto; Luigi Montalbano; Elena Gallo; Mario Cottone
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  Refractory ulcerative colitis accompanied with cytomegalovirus colitis and multiple liver abscesses: a case report.

Authors:  Takuya Inoue; Ichiro Hirata; Yutaro Egashira; Kumi Ishida; Ken Kawakami; Eijiro Morita; Naoko Murano; Shingo Yasumoto; Mitsuyuki Murano; Ken Toshina; Takashi Nishikawa; Norihiro Hamamoto; Ken Nakagawa; Ken-Ichi Katsu
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

6.  Prognostic factors for colectomy in refractory ulcerative colitis treated with calcineurin inhibitors.

Authors:  Shigeki Bamba; Akira Andoh; Hirotsugu Imaeda; Hiromitsu Ban; Ayako Kobori; Yousuke Mochizuki; Makoto Shioya; Takashi Nishimura; Osamu Inatomi; Masaya Sasaki; Yasuharu Saitoh; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  Exp Ther Med       Date:  2012-04-11       Impact factor: 2.447

7.  Cytomegalovirus enteritis causing ileal perforation in an elderly immunocompetent individual.

Authors:  Jae Myung Cha; Joung Il Lee; Jae Won Choe; Kwang Ro Joo; Sung Won Jung; Hyun Phil Shin; Sung Il Choi
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

8.  Cytomegalovirus positive ulcerative colitis: A single center experience and literature review.

Authors:  Uri Kopylov; Gila Sasson; Bella Geyshis; Michal Tepperberg Oikawa; Iris Barshack; Rami Eliakim; Shomron Ben-Horin
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15

Review 9.  Antiviral therapy in cytomegalovirus-positive ulcerative colitis: a systematic review and meta-analysis.

Authors:  Uri Kopylov; Noa Eliakim-Raz; Andrew Szilagy; Ernest Seidman; Shomron Ben-Horin; Lior Katz
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Primary infection with cytomegalovirus in ulcerative colitis.

Authors:  Stanley I Martin; Alireza Sepehr; Jay A Fishman
Journal:  Dig Dis Sci       Date:  2006-11-22       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.